908 Devices News

908 Devices Analyst Ratings

BenzingaMay 13 10:34 ET

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)

TipRanksMay 2 02:30 ET

Stifel Nicolaus Remains a Buy on 908 Devices (MASS)

TipRanksMar 6 07:40 ET

Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target

BenzingaSep 25, 2023 09:50 ET

908 Devices Analyst Ratings

BenzingaSep 25, 2023 09:49 ET

908 Devices (MASS) Receives a Buy From SVB Securities

TipRanksMar 8, 2023 23:07 ET

908 Devices Analyst Ratings

Benzinga Analyst RatingsFeb 7, 2023 05:03 ET

Stephens & Co. Initiates Coverage On 908 Devices With Overweight Rating, Announces Price Target of $14

Benzinga Real-time NewsFeb 7, 2023 05:03 ET

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), 908 Devices (MASS) and Privia Health Group (PRVA)

TipRanksJan 18, 2023 07:55 ET

SVB Securities Sticks to Its Buy Rating for 908 Devices (MASS)

TipRanksJan 6, 2023 11:30 ET

SVB Securities Adjusts 908 Devices' Price Target to $20 From $30, Keeps Outperform Rating

MT NewswiresJan 6, 2023 10:59 ET

908 Devices Analyst Ratings

Benzinga Analyst RatingsJan 6, 2023 09:08 ET

SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $20

Benzinga Real-time NewsJan 6, 2023 09:08 ET

SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)

TipRanksNov 15, 2022 07:45 ET

908 Devices Analyst Ratings

Benzinga Analyst RatingsNov 15, 2022 04:03 ET

SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $25

Benzinga Real-time NewsNov 15, 2022 04:01 ET

SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)

TipRanksAug 10, 2022 23:20 ET